Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP4 | P27487 | 1/20 | 0.49 |
| ▸ | MMP2 | P08253 | 1/20 | 0.49 |
| ▸ | MMP9 | P14780 | 1/20 | 0.49 |
| ▸ | MMP12 | P39900 | 1/20 | 0.49 |
| ▸ | MMP13 | P45452 | 1/20 | 0.49 |
| ▸ | MMP14 | P50281 | 1/20 | 0.49 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.47 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.46 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.46 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.46 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | ANPEP | P15144 | 2/20 | 0.44 |
| ▸ | ERAP1 | Q9NZ08 | 2/20 | 0.44 |
| ▸ | ERAP2 | Q6P179 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL108799 | 1.00 | DPP4 (0.49) | DPP4MMP2MMP9MMP12MMP13 | |
| SCHEMBL27897101 | 0.90 | MMP12 (0.49) | DPP4MMP2MMP9MMP12MMP13 | |
| SCHEMBL5950465 | 0.89 | MMP12 (0.44) | MMP2MMP9MMP12MMP13MMP14 | |
| SCHEMBL14088112 | 0.88 | MMP12 (0.65) | MMP2MMP9MMP12MMP13MMP14 | |
| SCHEMBL2820906 | 0.88 | TRPA1 (0.50) | TRPA1SLC6A2SLC6A4SLC6A3KCNH2 | |
| SCHEMBL4799370 | 0.86 | MMP2 (0.55) | DPP4MMP2MMP9MMP12MMP13 | |
| SCHEMBL1678559 | 0.86 | TRPA1 (0.57) | TRPA1 | |
| SCHEMBL14402642 | 0.85 | TSHR (0.49) | DPP4MMP2MMP9MMP12MMP13 | |
| SCHEMBL14968476 | 0.85 | TSHR (0.49) | DPP4MMP2MMP9MMP12MMP13 | |
| SCHEMBL2820904 | 0.85 | TSHR (0.49) | DPP4MMP2MMP9MMP12MMP13 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160067263-A1 | METHODS AND COMPOSITIONS FOR TOPICAL DELIVERY OF PROSTAGLANDINS TO SUBCUTANEOUS FAT | TOPOKINE THERAPEUTICS, INC. (US) | 2016-03-10 | — | — | US | disclosed |
| US-20110251390-A1 | NICOTINE-BASED COMPOUNDS USEFUL FOR ASYMMETRIC SYNTHESIS | NORTH CAROLINA STATE UNIVERSITY | 2011-10-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160067263-A1 | METHODS AND COMPOSITIONS FOR TOPICAL DELIVERY OF PROSTAGLANDINS TO SUBCUTANEOUS FAT | FFAR1, FFAR4, FFAR2 | DPP4 2830/4885MMP2 1460/4885MMP9 1337/4885 |
| US-20110251390-A1 | NICOTINE-BASED COMPOUNDS USEFUL FOR ASYMMETRIC SYNTHESIS | PNMT, NAPRT, PHOSPHO1 | DPP4 4246/4885MMP2 4821/4885MMP9 4788/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.